Valuation: PAVmed Inc.

Market Cap 15.73M 14.02M 12.99M 11.81M 22.17M 1.49B 22.53M 156M 61.28M 780M 59.03M 57.79M 2.49B P/E 2026 *
-0.62x
P/E 2027 * -1.14x
Enterprise Value 15.73M 14.02M 12.99M 11.81M 22.17M 1.49B 22.53M 156M 61.28M 780M 59.03M 57.79M 2.49B EV / Sales 2026 *
67.7x
EV / Sales 2027 * 26.2x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day-6.64%
1 week-16.36%
Current month-39.02%
1 month-43.18%
3 months-62.03%
6 months-75.33%
Current year-66.03%
1 week 2.2
Extreme 2.2
2.6
1 month 2.2
Extreme 2.2
4.33
Current year 2.2
Extreme 2.2
28.44
1 year 2.2
Extreme 2.2
28.44
3 years 2.2
Extreme 2.2
146.25
5 years 2.2
Extreme 2.2
2,853
10 years 2.2
Extreme 2.2
5,454
Manager TitleAgeSince
Compliance Officer 62 31/03/2023
Chief Executive Officer 60 25/06/2014
Director of Finance/CFO 68 28/02/2019
Director TitleAgeSince
Director/Board Member 60 30/09/2014
Chairman 60 25/06/2014
Director/Board Member 71 31/12/2014
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/26 Free

Chief Technology Officer

70,000 1.0966%
02/04/26 Free

Chief Operating Officer

110,000 1.7233%
02/04/26 Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
-6.64%-16.36%-85.21%-98.24% 15.73M
-1.54%+2.59%+26.06%+44.65% 251B
-2.01%+1.46%+7.35%+8.26% 158B
+1.52%+1.30%-2.90%+58.41% 153B
+1.49%+2.76%-54.60%-10.88% 65.29B
-0.07%+2.81%-15.15%-10.78% 51.23B
+2.08%+7.08%+11.66%+56.70% 51.29B
+0.72%+0.96%+16.85%+26.26% 50.27B
-1.77%-0.83%+19.72%+55.15% 47.9B
-0.61%+0.50%+29.79%+72.10% 42.67B
Average -0.85%+0.32%-4.64%+20.16% 87.07B
Weighted average by Cap. -0.69%+2.64%+7.56%+34.62%

Financials

2026 *2027 *
Net sales 232K 207K 192K 175K 328K 22.04M 333K 2.3M 905K 11.52M 872K 854K 36.83M 600K 535K 495K 450K 845K 56.89M 859K 5.94M 2.34M 29.73M 2.25M 2.2M 95.04M
Net income -23.17M -20.66M -19.13M -17.4M -32.65M -2.2B -33.18M -230M -90.25M -1.15B -86.94M -85.12M -3.67B -20.15M -17.96M -16.64M -15.13M -28.39M -1.91B -28.85M -200M -78.47M -998M -75.6M -74.01M -3.19B
Net Debt - -
Projected Income Statement - Annual - PAVmed Inc.
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
19/10/26 US$2.250 -6.64% 30,099
16/10/26 US$2.410 -0.62% 12,594
15/10/26 US$2.425 +5.90% 8,433
14/10/26 US$2.290 -13.26% 6,369
13/10/26 US$2.640 -1.86% 3,243
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - PAVmed Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.250USD
Average target price
36.50USD
Spread / Average Target
+1,522.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PAVmed Inc.
  1. Stock Market
  2. Stocks
  3. PAVM Stock